Kathryn M. Boxmeyer
Profile
Ms. Kathryn M.
Boxmeyer is Treasurer at Paratek Pharmaceuticals, Inc.
Ms. Boxmeyer was previously employed as Chief Financial Officer, Treasurer & VP by Paratek Pharmaceuticals, Inc. and Chief Financial Officer by Profile Technologies, Inc.
She received her undergraduate degree from Harvard University and an MBA from the Tuck School of Business at Dartmouth.
Former positions of Kathryn M. Boxmeyer
Companies | Position | End |
---|---|---|
WaveTrue, Inc.
WaveTrue, Inc. Miscellaneous Commercial ServicesCommercial Services WaveTrue, Inc. operates as a developer and service provider of technologies used to inspect pipelines for corrosion and other anomalous conditions. The company was founded in 1986 and is headquartered in New York, NY. | Director of Finance/CFO | 2014-12-17 |
PARATEK PHARMACEUTICALS, INC. | Director of Finance/CFO | 2014-12-17 |
Paratek Pharmaceuticals, Inc. /Old/
Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Paratek Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the discovery, development, and commercialization of medicines. The firm’s lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. The company was founded by Stuart B. Levy and Walter A. Gilbert on July 3, 1996 and is headquartered in Boston, MA. | Director of Finance/CFO | - |
Training of Kathryn M. Boxmeyer
Harvard University | Undergraduate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
PARATEK PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
Paratek Pharmaceuticals, Inc. /Old/
Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Paratek Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the discovery, development, and commercialization of medicines. The firm’s lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. The company was founded by Stuart B. Levy and Walter A. Gilbert on July 3, 1996 and is headquartered in Boston, MA. | Health Technology |
WaveTrue, Inc.
WaveTrue, Inc. Miscellaneous Commercial ServicesCommercial Services WaveTrue, Inc. operates as a developer and service provider of technologies used to inspect pipelines for corrosion and other anomalous conditions. The company was founded in 1986 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Kathryn M. Boxmeyer